AAD
Author: Willhemenia Loremipsum Special session: Lorem ipsum dolor sit amet Category: Lorem ipsum View all results

Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Clinical Considerations in Managing Women with Psoriasis

Description

The presentation focuses on the clinical considerations of managing women with psoriasis, emphasizing the need for a gender-sensitive approach in medical care. It highlights key learning objectives, including understanding gender differences in psoriasis, recognizing the unique challenges faced by women, and discussing family planning, particularly for women who are sexually active but do not plan to become pregnant. Hormonal fluctuations during significant life stages, such as menopause and pregnancy, are explored as they can affect the severity and management of psoriasis. Menopause often leads to disease exacerbation, while many women experience improvement during pregnancy, suggesting potential links to hormonal changes. The speaker encourages initiating conversations about contraception and family planning among providers and patients, noting that many women may not disclose their reproductive intentions or concerns. Additionally, the implications of psoriasis on pregnancy outcomes are reviewed, with reassuring findings indicating that psoriasis does not adversely affect fertility or pregnancy outcomes. The importance of postpartum care is underscored, as psoriasis often reoccurs after childbirth. Lastly, it reinforces that new biologics may allow for effective management of psoriasis during pregnancy and breastfeeding, advising caution while balancing potential risks for mothers and infants.

View more

Conclusions

  • Women with psoriasis represent a unique subpopulation with distinct clinical presentations and challenges.
  • Psoriasis prevalence is equal in men and women, but it often presents at a younger age in women, highlighting different disease experiences.
  • Women with psoriasis may experience higher disease progression and report worse quality of life compared to men, despite having lower skin severity scores.
  • Pregnancy generally shows an improvement in psoriasis for 50-75% of cases, but family planning discussions are crucial for sexually active women who may not want to conceive.
  • Hormonal changes due to menstruation, pregnancy, and menopause play significant roles in the management and exacerbation of psoriasis in women.
  • Hormone replacement therapy may increase the risk of developing psoriasis in postmenopausal women.
  • Effective communication and initiating discussions about family planning, contraception, and treatment options are essential for healthcare providers managing women with psoriasis.
  • Systemic treatments and biologics can often be safely used during pregnancy, and postpartum care requires careful consideration as psoriasis may return post-delivery.
  • Colombo D, Cassano N, Bellia G, Vena GA. Gender medicine and psoriasis. World J Dermato/ 2014; 3(3): 36-44
  • Guillet C, Seeli C, Nina M, Maul LV, Maul JT. The impact of gender and sex in psoriasis: What to be aware of when treating women with psoriasis. Int J Womens Dermatol. 2022 Apr
  • Murer C, Sgier D, Mettler SK, Guillet C, Maul JT, Djamei V, Navarini AA, Anzengruber F. Gender differences in psoriasis: a Swiss online psoriasis survey. Arch Dermatol Res. 2021 Mar;313(2):89-94.
  • N. Lesuis, R. Befrits, F. Nyberg, R.F. van Vollenhoven. Gender and the treatment of immune-mediated chronic inflammatory diseases: rheumatoid arthritis, inflammatory bowel disease and psoriasis: An observational study BMC Med, 10 (2012), p. 82
  • M. Hawro, M. Maurer, K. Weller, R. Maleszka, A. Zalewska-Janowska, A. Kaszuba, et al. Lesions on the back of hands and female gender predispose to stigmatization in patients with psoriasis. J Am Acad Dermatol, 76 (2017), pp. 648-654.e2
  • Ceovic R, Mance M, Mokos Z, Svetec M, Kostovic K, and Buzina D, "Psoriasis: Female Skin Changes in Various Hormonal Stages throughout Life-Puberty, Pregnancy, and Menopause," BioMed Research International, vol. 2013, Article ID 571912, 6 pages, 2013.
  • Go GM, Oh HJ, Han K, Kim YH, Lee HJ, Lee JH. Hormone Replacement Therapy and Psoriasis Risk: A Nationwide Population-Based Cohort Study. J Korean Med Sci. 2023 Dec 18;38(49):e377. doi: 10.3346/jkms.2023.38.e377. PMID: 38111280; PMCID: PMC10727922.
  • Murase , JE Hormonal effect on psoriasis in pregnancy and post partum. Arch Dermtol, May 2005;14(5);601-606.
  • Bobotsis R, et al. Systematic review of 9 studies of 4,756 pregnancies: Br J Dermatol. 2016 Jul 24;175:464-72.
  • Yeung J, Gooderham MJ, Grewal P, Hong CH, Lansang P, Papp KA, Poulin Y, Turchin I, Vender R. Management of Plaque Psoriasis With Biologic Therapies in Women of Child-Bearing Potential Consensus Paper. J Cutan Med Surg. 2020 Jul/Aug;24(1_suppl):3S-14S. doi: 10.1177/1203475420928376. Epub 2020 Jun 5. PMID: 32500730.
  • Butler DC, Heller MM, Murase JE. Safety of dermatologic medications in pregnancy and lactation: Part II. Lactation. J Am Acad Dermatol. 2014 Mar;70(3):417.e1-10; quiz 427. doi: 10.1016/j.jaad.2013.09.009.
  • 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis Care Res (Hoboken). 2020 Apr;72(4):461-488. doi: 10.1002/acr.24130. Epub 2020 Feb 26.
  • Clowse ME et al. Minimal to no transfer of certolizumab into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study. Ann Rheum Dis. 2017 Nov;76(11):1890-1896.